Alexander El Gammal
Dr. med.
Alexander T. El Gammal
  • Wissenschaftlicher Mitarbeiter
Arbeitsbereich

Standort

Hauptgebäude O10 , 2. Etage
Sprachen
Deutsch (Muttersprache)
Englisch

Fachgebiete

Tätigkeitsschwerpunkte

Mitgliedschaften

Publikationen

Zurück
  • 2017
  • 2015
  • 2014
  • 2010
Vor

HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer
Bogoevska V, Wolters-Eisfeld G, Hofmann B, El Gammal A, Mercanoglu B, Gebauer F, Vashist Y, Bogoevski D, Perez D, Gagliani N, Izbicki J, Bockhorn M, Güngör C
ONCOGENE. 2017;36(17):2394-2404.

Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases
El Gammal A, H Sturm J, Pinnschmidt H, Hofmann B, Bellon E, Ghadban T, Melling N, Bachmann K, Izbicki J, Bockhorn M, Güngör C, Perez D
Int J Clin Endocrinol Metab. 2017;3(1):023-028.

Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management.
El Gammal A, Izbicki J
SURG CLIN N AM. 2017.

Buchkapitel: Pankreatikoduodenektomie
El Gammal A, Perez D, Izbicki J
2017. Expertise Pankreas. Georg Thieme Verlag KG, 27-33.

Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort
Wolter S, Duprée A, Coelius C, El Gammal A, Kluwe J, Sauer N, Mann O
OBES SURG. 2017;27(1):90-95.

Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry
Bachmann K, Neumann A, Hinsch A, Nentwich M, El Gammal A, Vashist Y, Perez D, Bockhorn M, Izbicki J, Mann O
J SURG ONCOL. 2015;111(3):316-23.

Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, El Gammal A, Miro J, Wellner U, Pantel K, Izbicki J, Vashist Y
CANCER GENET-NY. 2015;208(12):595–601.

Correction to: An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, Tsui T, El Gammal A, Erbes P, Zilbermints V, Wellner U, Pantel K, Izbicki J, Vashist Y
J HUM GENET . 2015;60(2):107.

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
Hofmann B, Schlüter L, Lange P, Mercanoglu B, Ewald F, Fölster A, Picksak A, Harder S, El Gammal A, Grupp K, Güngör C, Drenckhan A, Schlüter H, Wagener C, Izbicki J, Jücker M, Bockhorn M, Wolters-Eisfeld G
MOL CANCER. 2015;14(1):109.

Salvage Completion Pancreatectomies as Damage Control for Post-pancreatic Surgery Complications: A Single-Center Retrospective Analysis
Nentwich M, El Gammal A, Lemcke T, Ghadban T, Bellon E, Melling N, Bachmann K, Reeh M, Uzunoglu F, Izbicki J, Bockhorn M
WORLD J SURG. 2015;39(6):1550-6.

Obesity research: Status quo and future outlooks
El Gammal A, Dupree A, Wolter S, Aberle J, Izbicki J, Güngör C, Mann O
World J of Transl Med. 2014;3(3):119-132.

The role of RANK-signaling in tumor cell proliferation and migration in pancreatic adenocarcinoma.
El Gammal A, Sander N, Aljonna F, Friedenberger H, Leonie K, Güngör C, Wolters-Eisfeld G, Hofmann B, Bockhorn M, Izbicki J, Perez D
2014.

Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors
Ghadban T, Perez D, Vashist Y, Bockhorn M, Koenig A, El Gammal A, Izbicki J, Metzger U, Hauswirth F, Frosina D, Jungbluth A
EJSO-EUR J SURG ONC. 2014;40(10):1307-1312.

An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, Tsui T, El Gammal A, Erbes P, Zilbermints V, Wellner U, Pantel K, Izbicki J, Vashist Y
J HUM GENET . 2014;59(12):661-666.

Zertifizierungen in der onkologischen Chirurgie: Bedeutung für die Wahl der Behandlungsstätte
Melling N, Drabik A, El Gammal A, Antonakis F, Darmann I, Izbicki J, Bockhorn M
CHIRURG. 2014;86(7):687-695.

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
El Gammal A, Brüchmann M, Zustin J, Isbarn H, Hellwinkel O, Köllermann J, Sauter G, Simon R, Wilczak W, Schwarz J, Bokemeyer C, Brümmendorf T, Izbicki J, Yekebas E, Fisch M, Huland H, Graefen M, Schlomm T
CLIN CANCER RES. 2010;16(1):56-64.

Letzte Aktualisierung aus dem FIS: 18.02.2018 - 00:09 Uhr